of plague patients, results from aerosol exposure to infective droplets and is characterized by a fulminant primary pneumonia. Secondary pneumonic plague can result from the spread of Y. pestis to the lungs in patients with untreated bubonic or septicemic infection.
The mortality rate for untreated plague has ranged from 66% to 93%; however, in the antibiotic era, mortality has been reduced to approximately 16% (4). Prompt treatment with antimicrobials such as aminoglycosides, fluoroquinolones, or doxycycline greatly improves outcome (4) .
Health care providers should consider the diagnosis of plague in any patient with compatible signs or symptoms, residence or travel in the western United States, and recent proximity to rodent habitats or direct contact with rodents or ill domestic animals. Suspicion of plague should prompt 1) collection of blood, bubo aspirate, or sputum samples for Y. pestis diagnostic testing; 2) implementation of isolation and respiratory droplet precautions for patients with respiratory involvement; 3) immediate antibiotic treatment (before laboratory confirmation); and 4) notification of public health officials. Y. pestis-specific testing is available at state health laboratories. Recommendations for diagnostic testing and antibiotic treatment are available at http://www.cdc.gov/plague/healthcare/ clinicians.html. Misidentification of Y. pestis as Pseudomonas luteola and other organisms through the use of automated bacterial identification systems has been reported (5).
Persons engaging in outdoor activities in areas where plague is endemic should wear long pants when possible and use insect repellent on clothing and skin. Persons also should avoid direct contact with ill or dead animals and never feed squirrels, chipmunks, or other rodents. In addition, pet owners should regularly use flea control products on their pets and consult a veterinarian if their pet is ill. Rodent habitat can be reduced 
